JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
Li J, Nie L, Zhao Y, Zhang Y, Wang X, Wang S, Liu Y, Zhao H, Cheng L. IL-17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells. Journal of Translational Medicine. 2016 Mar 17;14(1):77. doi: 10.1186/s12967-016-0833-9.; Bogoyevitch MA. The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting. Bioessays. 2006 Sep;28(9):923–34. doi: 10.1002/bies.20458. PMID: 16937364.; Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M. Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes. J Biol Chem. 2005 Jul 29;280(30):27728–41. doi: 10.1074/jbc.m411657200. PMID: 15837794.; Sundarrajan M, Boyle DL, Chabaud-Riou M, Hammaker D, Firestein GS. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum. 2003 Sep;48(9):2450–60. doi: 10.1002/art.11228. PMID: 13130464.; Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001 Jul 19;412(6844):346–51. doi: 10.1038/35085597. PMID: 11460167.; Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. Defective T cell differentiation in the absence of Jnk1. Science. 1998 Dec 11;282(5396):2092–5. doi: 10.1126/science.282.5396.2092. PMID: 9851932.; Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994 May 12;369(6476):156–60. doi: 10.1038/369156a0. PMID: 8177321.